scholarly article | Q13442814 |
P356 | DOI | 10.1111/BJH.12764 |
P8608 | Fatcat ID | release_nhcs5vak2ncbhl5xaa27w2h6xq |
P698 | PubMed publication ID | 24521452 |
P2093 | author name string | William Beau Mitchell | |
Mauro P Avanzi | |||
P2860 | cites work | Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors | Q24305025 |
Functional cross-antagonism between transcription factors FLI-1 and EKLF | Q24541389 | ||
Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells | Q24630871 | ||
Transcription factors in late megakaryopoiesis and related platelet disorders | Q27015841 | ||
Concise review: heart regeneration and the role of cardiac stem cells | Q27021931 | ||
Pluripotent stem cells reveal the developmental biology of human megakaryocytes and provide a source of platelets for clinical application | Q27026899 | ||
Terminal platelet production is regulated by von Willebrand factor | Q27320100 | ||
Induced regeneration--the progress and promise of direct reprogramming for heart repair | Q27687630 | ||
Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
Bone marrow osteoblastic niche: a new model to study physiological regulation of megakaryopoiesis | Q28472310 | ||
Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells | Q28587254 | ||
RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation | Q30310497 | ||
Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices | Q30480500 | ||
Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells | Q30483213 | ||
Infusion of mature megakaryocytes into mice yields functional platelets | Q30497158 | ||
Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes | Q30502470 | ||
Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study). | Q33293979 | ||
Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children | Q33334328 | ||
The role of transcription factor NF-E2 in megakaryocyte maturation and platelet production | Q33334400 | ||
BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation | Q33343732 | ||
Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets | Q33349386 | ||
Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis | Q33358404 | ||
The biogenesis of platelets from megakaryocyte proplatelets | Q33369405 | ||
Regulation of proplatelet formation and platelet release by integrin alpha IIb beta3. | Q33371086 | ||
Megakaryocyte development and platelet production. | Q33372021 | ||
Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates | Q33375326 | ||
Megakaryopoiesis | Q33390616 | ||
Apoptotic processes in megakaryocytes and platelets | Q37771608 | ||
Ex vivo expansion of umbilical cord blood for transplantation | Q37788414 | ||
Platelets: covert regulators of lymphatic development | Q37808903 | ||
Contribution of platelets to tumour metastasis. | Q37831798 | ||
Challenges and promises for the development of donor-independent platelet transfusions | Q38074224 | ||
Challenges in the management of the blood supply | Q38109322 | ||
This niche is a maze; an amazing niche | Q38468327 | ||
Culture of megakaryocytes and platelets from subcutaneous adipose tissue and a preadipocyte cell line | Q39435054 | ||
Ex vivo large-scale generation of human platelets from cord blood CD34+ cells | Q40290226 | ||
Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. | Q40328019 | ||
Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytes. | Q40335716 | ||
Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. | Q40464481 | ||
Generation of functional culture-derived platelets from CD34+ progenitor cells to study transgenes in the platelet environment | Q40490925 | ||
Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept | Q41924284 | ||
Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition | Q42008823 | ||
c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors | Q42025382 | ||
Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions | Q42606543 | ||
Prolonged continuous in vitro human platelet production using three-dimensional scaffolds | Q43136245 | ||
Platelet formation is the consequence of caspase activation within megakaryocytes | Q44083637 | ||
The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability | Q45102758 | ||
Anomalous megakaryocytopoiesis in mice with mutations in the c-Myb gene | Q45234484 | ||
Megakaryocyte-matrix interaction within bone marrow: new roles for fibronectin and factor XIII-A. | Q46501234 | ||
Modifying murine von Willebrand factor A1 domain for in vivo assessment of human platelet therapies | Q46847132 | ||
Developmental differences in megakaryocyte size in infants and children | Q47303380 | ||
Blood collection and transfusion in the United States in 2001. | Q50704141 | ||
Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design. | Q50955292 | ||
Interrelation between polyploidization and megakaryocyte differentiation: a gene profiling approach. | Q51999245 | ||
Deregulated expression of c-myc in megakaryocytes of transgenic mice increases megakaryopoiesis and decreases polyploidization. | Q52199791 | ||
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. | Q53457979 | ||
Cytokinesis and the spindle midzone. | Q53651265 | ||
Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis. | Q53734886 | ||
Dynamic Visualization of Thrombopoiesis Within Bone Marrow | Q58450371 | ||
Neonatal thrombocytopenia and megakaryocytopoiesis | Q33390642 | ||
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells | Q33392928 | ||
Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets | Q33397149 | ||
Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function | Q33399439 | ||
High doses of romiplostim induce proliferation and reduce proplatelet formation by human megakaryocytes | Q33405562 | ||
Infusion of megakaryocytic progenitor products generated from cord blood hematopoietic stem/progenitor cells: results of the phase 1 study | Q33405752 | ||
Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside. | Q33407110 | ||
Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution | Q33642298 | ||
Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice | Q33789872 | ||
Anucleate platelets generate progeny | Q33834761 | ||
Genetic analysis of hierarchical regulation for Gata1 and NF-E2 p45 gene expression in megakaryopoiesis | Q33876985 | ||
Induction of platelet formation from megakaryocytoid cells by nitric oxide | Q33951944 | ||
Lineage-specific hematopoietic growth factors | Q33995753 | ||
Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. | Q34036700 | ||
Microtubules, membranes and cytokinesis | Q34078465 | ||
Generation of HLA-deficient platelets from hematopoietic progenitor cells | Q34111574 | ||
Constitutively released adenosine diphosphate regulates proplatelet formation by human megakaryocytes | Q34280678 | ||
AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis | Q34299077 | ||
Roads to polyploidy: the megakaryocyte example | Q34504475 | ||
Understanding Cytokinesis Failure | Q34717820 | ||
Three-dimensional system for the in vitro study of megakaryocytes and functional platelet production using silk-based vascular tubes | Q35579676 | ||
Role of apoptotic processes in platelet biogenesis | Q35596713 | ||
Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1. | Q35848534 | ||
Platelets: physiology and biochemistry | Q36251970 | ||
Cytokinesis: welcome to the Rho zone | Q36294256 | ||
Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent death | Q36324970 | ||
Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf | Q36370865 | ||
Cytokinesis: placing and making the final cut. | Q37018205 | ||
Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors | Q37052835 | ||
Platelets as cellular effectors of inflammation in vascular diseases | Q37081746 | ||
Cord-blood engraftment with ex vivo mesenchymal-cell coculture | Q37247837 | ||
Platelet production by megakaryocytes: protoplatelet theory justifies cytoplasmic fragmentation model | Q37254273 | ||
Regulation of megakaryocyte maturation and platelet formation. | Q37561574 | ||
In vitro megakaryocyte production and platelet biogenesis: state of the art | Q37644828 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 237-247 | |
P577 | publication date | 2014-02-13 | |
P1433 | published in | British Journal of Haematology | Q4970200 |
P1476 | title | Ex vivo production of platelets from stem cells | |
P478 | volume | 165 |
Q47610507 | 2017 Military Supplement: Hemoglobin-based Oxygen Carriers: Current State-of-the-Art and Novel Molecules. |
Q92546005 | A comparison of haematopoietic stem cells from umbilical cord blood and peripheral blood for platelet production in a microfluidic device |
Q39179984 | Bio-inspired nanomedicine strategies for artificial blood components |
Q47324534 | Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding. |
Q46265048 | Dopamine induces platelet production from megakaryocytes via oxidative stress-mediated signaling pathways |
Q35836174 | Embryonic stem cells as sources of donor-independent platelets |
Q92219763 | Enabling Large-Scale Ex Vivo Production of Megakaryocytes from CD34+ Cells Using Gas-Permeable Surfaces |
Q88072705 | Enhancing functional platelet release in vivo from in vitro-grown megakaryocytes using small molecule inhibitors |
Q47879370 | Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin |
Q27310713 | IL-1α induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs |
Q36358673 | Identifying and enriching platelet-producing human stem cell-derived megakaryocytes using factor V uptake. |
Q97533489 | In vitro platelet production for transfusion purposes: Where are we now? |
Q33424186 | Manipulating megakaryocytes to manufacture platelets ex vivo |
Q64266287 | Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line |
Q38830108 | Megakaryocytic differentiation of mouse embryonic stem cells via coculture with immortalized OP9 stromal cells |
Q57167167 | On the Way to Platelet Production |
Q57166306 | On the way to in vitro platelet production |
Q40115861 | Platelet production from induced pluripotent stem cells |
Q94519266 | Previews |
Q47597555 | Producing megakaryocytes from a human peripheral blood source |
Q39076420 | Progress in bio-manufacture of platelets for transfusion |
Q34671302 | Road blocks in making platelets for transfusion |
Q26770860 | Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets |
Q56362506 | Whirling Platelets Away for Transfusion |
Search more.